The OxyMPa smart device is the result of nearly a decade of round-the-clock efforts of the research and development team of Mobtakeran Sanat Pajouh Company (MOSAP). After passing all the international and mandatory standards of the national medical device directorate, OxyMPa has been able to be introduced to medical centers around the world as the beating heart of hospital oxygen sites by receiving a license to manufacture medical products and unique privileges and capabilities.
OxyMPa smart device has the ability to continuously monitor and control the Min-Max allowable range defined for the basic parameters of oxygen gas injected into the hospital central piping system, as well as simulation and monitoring of flow, purity, pressure and temperature parameters of these devices by highly advanced data transponders. Utilizing artificial intelligence technology, OxyMPa is responsible for monitoring, controlling and regulating all the important equipment and events of your hospital's central oxygen site, and while providing intelligent support and monitoring of the liquid oxygen line along with two high oxygen pressure lines with automatic adjustment, conditions Provides fully professional monitoring and control over the supply of oxygen to the hospital's central consumption for the management team of the mentioned sites. Features such as Alternately Rest Time instructions in accordance with international standards, SMS communication with the management team of Central Oxygen site and hospital officials, storage and archiving of useful information about the operation of the devices and the possibility of printing this information are other useful features of the OxyMPa smart device.
Read moreMobtakeran Sanat Pajouh (MOSAP) Company
Mobtakeran Sanat Pajouh (MOSAP) Company, as a manufacturing research company with nearly two decades of professional activity in the field of hospital central medical gases and cooperation with reputable international companies, has succeeded in inventing a unique way to support hospital oxygen consumption.
The result of several years of practice and effort along with experiments and scientific research in MOSAP Company, several valid patents in the member states of the Paris Convention and this company has been able to proudly introduce the OxyMPa smart device as the beating heart of medical gas sites of medical centers to the country's medical system.
